Bibliography
- Klein M. Multicenter trial of cefpodoxime proxetil vs. amoxicillin-clavulanate in acute lower respiratory tract infections in childhood. International Study Group. Pediatr Infect Dis J 1995;14(4 Suppl):S19-22
- Bush K. New β-lactamases in Gram-negative bacteria: diversity and impact on selection of antimicrobial therapy. Clin Infect Dis 2001;32:1085-9
- Virk A, Steckelberg JM. Clinical aspects of antimicrobial resistance. Mayo Clin Proc 2000;75:200-14
- Fantin B, Pangon B, Potel G, et al. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like β-lactamase. Antimicrob Agents Chemother 1990;34:581-6
- Prabhakaran K, Harris EB, Randhawa B. Bacterial action of ampicillin/sulbactam against intracellular mycobacteria. Int J Antimicrob Agents 1999;13:133-5
- Hedberg M, Lindqvist L, Tuner K. Effect of β-lactamse inhibitors on beta-lactamases from anaerobic bacteria. Eur J Clin Microbial Infect Dis 1992;11:1100-4
- Eugene BB. Current guidelines for the treatment and prevention of nosocomial infections. Drugs 1999;58:51-67
- Young JPW, Husson JM, Bruch K. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases. J Antimicrob Chemother 1980;6:293-300
- Karachalios GN. Treatment of respiratory tract infections with a combination of amoxicillin and clavulanic acid. Int J Clin Pharmacol Ther Toxicol 1985;23:647-9
- Anyanwu CH, Umeh BU. A clinical evaluation of clavulanate-potentiated amoxicillin in the management of moderate to severe respiratory tract infections. J Int Med Res 1988;16:210-5
- Tatsis G, Veslemes M, Hadjistavrou C. Treatment of lower respiratory tract infections with amoxicillin/clavulanic acid in adults. J Int Med Res 1993;21:98-101
- Cook RC, Zachariah J, Cree F, Harrison HE. Efficacy of twice-daily amoxicillin/clavulanate (‘Augmentin-duo’ 400/57) in mild to moderate lower respiratory tract infection in children. Br J Clin Pract 1996;50(3):125-8
- Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-51